Dealing with the unexpected: Covid-19 and risk management
Major global events such as the ongoing Covid-19 pandemic can cause significant problems...
Focus:
-
![antibacterial clinical trial]()
EMA publishes revised guidelines on antibacterial drug development
-
![]()
Observations from GCP Sponsor Inspections
-
![]()
Is the GAIN Act Stimulating Antibiotic R&D?
-
![]()
The Future of Pfizer’s $5B Brand is in Jeopardy
-
![]()
The Top 5: November 2018
-
![]()
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
Most Read
Company A-Z
Latest Content
Dealing with the unexpected: Covid-19 and risk management
Major global events such as the ongoing Covid-19 pandemic can cause significant problems for clinical trials and pharma research programmes. Oncoinvent head of clinical operations Helén Johansen Blanco shares her expertise on proactive risk management and when a risk becomes an issue.
Worldwide selects ClinSpark eSource platform to automate trials
Worldwide Clinical Trials has implemented Foundry Health’s ClinSpark eSource Platform to automate Phase I first-in-human clinical trials for clinical development.
Signant Health offers eConsent support for oncology trial in UK
Clinical trial solutions provider Signant Health has agreed to provide electronic informed consent (eConsent) support for an oncology trial by the University of Bristol in the UK.
VirTrial enables virtual trials at Pratia site network
Clinical trials technology provider VirTrial has formed an alliance to enable virtual clinical trials at Pratia clinical research centres in Europe.
Parexel signs data technology deal with Datavant
Biopharmaceutical services provider Parexel has entered a multi-year collaboration with healthcare data services firm Datavant to link real-world data across clinical trials.
Survey finds downward trend in use of eClinical technologies
A new global survey commissioned by Oracle Health Sciences has found that investigational sites are facing challenges in adopting eClinical technologies due to disjointed techniques and complexity.
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of small molecule MYK-224 for the treatment of hypertrophic cardiomyopathy (HCM). Clinicaltrialsarena.com wraps up the key headlines from August 2019.
Idorsia Pharmaceuticals selects Arkivum to preserve clinical data
Switzerland-based Idorsia Pharmaceuticals has selected Arkivum to protect and digitally store its clinical trial and research data.
PCI Pharma to invest in new clinical facility in Dublin
PCI Pharma is set to invest in a new clinical facility near Dublin, Ireland to significantly increase capabilities and capacity for its clinical services business.
IQVIA enables direct patient access to trial information
IQVIA has launched a new web-based solution to offer patients a direct access point for clinical trial information following their enrolment.
Latest News
Close
Close
Close
Go Top